Quantcast

Latest Angina pectoris Stories

2008-08-19 09:01:12

PALO ALTO, Calif., Aug. 19 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. announced today that the Journal of Cardiovascular Electrophysiology has published a study of ranolazine showing that ranolazine significantly (p In the study, five patients with LQT3 syndrome were prospectively investigated during an eight hour intravenous infusion of therapeutic concentrations of ranolazine, with ECG and ECHO evaluation before, during and after ranolazine administration. LQT3 syndrome is caused...

2008-08-14 18:00:45

PALO ALTO, Calif., Aug. 14 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. announced today that it has received approval from the European Medicines Agency (EMEA) for the brand name Ranexa(R) (ranolazine). On July 10, 2008, the Company announced that the EMEA had granted marketing authorization for ranolazine in all 27 European Union (EU) member states under the brand name Latixa. "Securing approval for the Ranexa brand name in Europe provides important brand synergy in the world's two...

2008-08-14 15:00:59

PALO ALTO, Calif., Aug. 14 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. today announced that its chronic angina therapy Ranexa(R) (ranolazine extended-releases tablets) has been selected as a finalist for the prestigious Prix Galien USA 2008 award which honors the best pharmaceutical agent and best biotechnology product of the year. Winners will be announced on September 24, 2008 in New York. "Being named a finalist for the Prix Galien USA awards is a great honor. We congratulate the...

2008-06-30 18:02:10

MONTVALE, N.J., June 30, 2008 (PRIME NEWSWIRE) -- Ivivi Technologies, Inc. (Nasdaq:IVVI), a leader in non-invasive, electroceutical(r) therapy systems designed to enhance the body's natural anti-inflammatory response, today announced that the Cleveland Clinic, in Westin, Florida, has released the results of its double-blind, randomized, placebo-controlled and prospective clinical trial (EFFECT trial) utilizing the Company's proprietary targeted pulsed electromagnetic field (tPEMF(tm))...

2008-06-26 12:03:21

U.S. cardiologists have discovered nearly 1-in-5 patients experiences chest pain one year after suffering a heart attack. Dr. Thomas Maddox and colleagues at the Denver Veterans Affairs Medical Center and University of Colorado studied the occurrence of angina (episodic chest pain) in 1,957 patients from January 2003 to June 2004. The study showed of all patients, 389 (19.9 percent) reported angina one year after hospitalization for heart attack. Those patients were more likely to be...

2008-06-24 02:29:21

By Ask Dr. Ramo BARRY RAMO For the Journal Three weeks ago, I got a call from the wife of one of my longtime patients telling me that her 60-year-old husband had died suddenly at home while reading the newspaper. After Tim Russert died suddenly under similar circumstances, every patient in my cardiology practice asks "how could that happen" and "how can I keep it from happening to me?" Russert passed a stress test two months ago. He was taking blood pressure medication and a...

2008-06-24 02:29:21

PALO ALTO, Calif., June 23 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. today announced that the Archives of Internal Medicine published results of a major study demonstrating that one in five patients studied experienced chest pain one year after a myocardial infarction (MI), or heart attack, and that this angina was associated with significantly elevated rates of depression among cardiac patients in the registry. PREMIER (Prospective Registry Evaluating Myocardial Infarction: Events...

2007-02-28 12:01:36

St. Jude Medical, Inc. (NYSE:STJ) today announced the first patient implant in a pilot study that will preliminarily evaluate if stimulating nerves near the spinal cord will control chronic chest pain caused by angina. A 53-year-old Massachusetts woman is the first person to receive this investigational device, called the Genesis® Neurostimulation System. She is one of approximately 1.3 million Americans who suffer from chronic angina, according to the American...

2006-12-24 03:00:08

By Nasir, Javed M; Durning, Steven J; Sweet, Jon M; Cation, Lannie J Chest pain with electrocardiographic changes is usually a life- threatening presentation of cardiac ischemia. There are, however, a variety of noncardiac conditions that have been reported to mimic these clinical and electrocardiographic changes. An Asian woman presented with chest pain and ST segment elevations in the distribution of the left anterior descending artery. She had persisting chest pain and ST segment...

2006-08-02 10:30:00

By Megan Rauscher NEW YORK -- A large number of adults with both high blood pressure and high cholesterol are not receiving treatment, a study shows. High blood pressure, or hypertension, and high cholesterol (a.k.a., hypercholesterolemia), are two important modifiable risk factors for heart and circulatory disease. "We were surprised that, despite well-publicized guidelines and treatments available for hypertension and hypercholesterolemia, less than a third are being treated for both...


Word of the Day
holluschickie
  • A 'bachelor seal'; a young male seal which is prevented from mating by its herd's older males (mated bulls defending their territory).
This comes from the Russian word for 'bachelors.'
Related